These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 2555638

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.
    Coy DH, Taylor JE, Jiang NY, Kim SH, Wang LH, Huang SC, Moreau JP, Gardner JD, Jensen RT.
    J Biol Chem; 1989 Sep 05; 264(25):14691-7. PubMed ID: 2475489
    [Abstract] [Full Text] [Related]

  • 8. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
    Narayan S, Spindel ER, Rubin NH, Singh P.
    Cell Growth Differ; 1992 Feb 05; 3(2):111-8. PubMed ID: 1323998
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat.
    Coy DH, Mungan Z, Rossowski WJ, Cheng BL, Lin JT, Mrozinski JE, Jensen RT.
    Peptides; 1992 Feb 05; 13(4):775-81. PubMed ID: 1279632
    [Abstract] [Full Text] [Related]

  • 14. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT, Coy DH, Mantey SA, Jensen RT.
    J Pharmacol Exp Ther; 1995 Oct 05; 275(1):285-95. PubMed ID: 7562561
    [Abstract] [Full Text] [Related]

  • 15. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
    Cai RZ, Reile H, Armatis P, Schally AV.
    Proc Natl Acad Sci U S A; 1994 Dec 20; 91(26):12664-8. PubMed ID: 7809097
    [Abstract] [Full Text] [Related]

  • 16. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K, O'Byrne K, Cai RZ.
    Br J Cancer; 1994 Nov 20; 70(5):886-92. PubMed ID: 7947094
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
    Dietrich JB, Hildebrand P, Jeker LB, Pansky A, Eberle AN, Beglinger C.
    Regul Pept; 1994 Oct 21; 53(3):165-73. PubMed ID: 7531356
    [Abstract] [Full Text] [Related]

  • 19. Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists.
    Davis TP, Crowell S, Taylor J, Clark DL, Coy D, Staley J, Moody TW.
    Peptides; 1992 Oct 21; 13(2):401-7. PubMed ID: 1329046
    [Abstract] [Full Text] [Related]

  • 20. Hormonal control of avian pancreas by gastrin-releasing peptide from the proventriculus.
    Campbell B, Garner A, Dimaline R, Dockray GJ.
    Am J Physiol; 1991 Jul 21; 261(1 Pt 1):G16-21. PubMed ID: 1858884
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.